Revolutionizing immune research with organoid-based co-culture and chip systems
Clinical and Experimental Immunology · 16.09.2024 · 218 (1) · 40-54
DOI: 10.1093/cei/uxae004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 27.01.2024. Verfasst von Diana Papp und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Organoids, Coculture Techniques. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute Strategic Programme Food Microbiome and Health, Imperial Biomedical Research Centre Organoid Facility.
Abstract (Originalsprache)
The intertwined interactions various immune cells have with epithelial cells in our body require sophisticated experimental approaches to be studied. Due to the limitations of immortalized cell lines and animal models, there is an increasing demand for human in vitro model systems to investigate the microenvironment of immune cells in normal and in pathological conditions. Organoids, which are self-renewing, 3D cellular structures that are derived from stem cells, have started to provide gap-filling tissue modelling solutions. In this review, we first demonstrate with some of the available examples how organoid-based immune cell co-culture experiments can advance disease modelling of cancer, inflammatory bowel disease, and tissue regeneration. Then, we argue that to achieve both complexity and scale, organ-on-chip models combined with cutting-edge microfluidics-based technologies can provide more precise manipulation and readouts. Finally, we discuss how genome editing techniques and the use of patient-derived organoids and immune cells can improve disease modelling and facilitate precision medicine. To achieve maximum impact and efficiency, these efforts should be supported by novel infrastructures such as organoid biobanks, organoid facilities, as well as drug screening and host-microbe interaction testing platforms. All these together or in combination can allow researchers to shed more detailed, and often patient-specific, light on the crosstalk between immune cells and epithelial cells in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
- NIHR Imperial BRC Organoid Facility, Imperial College London, London, UK.
- Food, Microbiome and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
- Earlham Institute, Norwich Research Park, Norwich, UK.
ORCID-Profile: Tamas Korcsmaros
Förderung
- Institute Strategic Programme Food Microbiome and Health
- Imperial Biomedical Research Centre Organoid Facility
Zitieren
APA
Papp, D., Korcsmaros, T., & Hautefort, I. (2024). Revolutionizing immune research with organoid-based co-culture and chip systems. Clinical and Experimental Immunology, 218(1), 40-54. https://doi.org/10.1093/cei/uxae004
Vancouver
Papp D, Korcsmaros T, Hautefort I. Revolutionizing immune research with organoid-based co-culture and chip systems. Clinical and Experimental Immunology. 2024;218(1):40-54. doi:10.1093/cei/uxae004
BibTeX
@article{Papp2024,
author = {Papp, Diana and Korcsmaros, Tamas and Hautefort, Isabelle},
title = {Revolutionizing immune research with organoid-based co-culture and chip systems},
journal = {Clinical and Experimental Immunology},
year = {2024},
volume = {218},
number = {1},
pages = {40--54},
doi = {10.1093/cei/uxae004}
}
EUVIMED